HUTCHMED (China) (HMDCF) Tax Provisions (2015 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Tax Provisions came in at -$16.8 million in Q4 2021, down 350.16% quarter-over-quarter from $6.7 million in Q3 2021.
Analysis
HUTCHMED (China) (HMDCF) Tax Provisions (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Tax Provisions for 6 consecutive years, with -$16.8 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to -$16.8 million in Q4 2021; TTM through Dec 2021 was -$11.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$63.6 million, down 784.45% from the prior year.
- Tax Provisions was -$16.8 million for Q4 2021 at HUTCHMED (China), down from $6.7 million in the prior quarter.
- Over five years, Tax Provisions peaked at $6.7 million in Q3 2021 and troughed at -$16.8 million in Q4 2021.
- A 4-year average of -$947142.9 and a median of -$406000.0 in 2019 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 183.64% in 2019, down 188.83% in 2019.
- Over 4 years, Tax Provisions stood at $969000.0 in 2018, then sank by 173.79% to -$715000.0 in 2019, then plunged by 38.04% to -$987000.0 in 2020, then tumbled by 1597.87% to -$16.8 million in 2021.
- The last three Tax Provisions figures came in at -$16.8 million (Q4 2021), $6.7 million (Q3 2021), and $80000.0 (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -3.96 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -16.76 Mn |
| Sep 28, 2021 | 6.70 Mn |
| Jun 30, 2021 | 80,000.00 |
| Mar 31, 2021 | -1.94 Mn |
| Jun 30, 2020 | -987,000.00 |
| Mar 31, 2020 | -1.05 Mn |
| Dec 31, 2019 | -715,000.00 |
| Sep 30, 2019 | -97,000.00 |
| Jun 30, 2019 | -3.77 Mn |
| Mar 31, 2019 | 1.31 Mn |
| Dec 31, 2018 | 969,000.00 |
| Sep 30, 2018 | 315,000.00 |
| Jun 30, 2018 | 4.25 Mn |
| Mar 31, 2018 | -1.57 Mn |
| Jun 30, 2016 | 5.93 Mn |
| Jun 30, 2015 | 4.25 Mn |